Autoimmune Encephalitis Concomitant with SARS-CoV-2 Infection: Insight from 18F-FDG PET Imaging and Neuronal Autoantibodies

Stephan Grimaldi, Stanislas Lagarde, Jean-Robert Harlé, José Boucraut, Eric Guedj, Stephan Grimaldi, Stanislas Lagarde, Jean-Robert Harlé, José Boucraut, Eric Guedj

Abstract

We report the case of a 72-y-old man with concomitant autoimmune encephalitis and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The patient presented with subacute cerebellar syndrome and myoclonus several days after general infectious symptoms began. Methods: Clinical examination, CT, PET, MRI, and autoantibody testing were performed. Results: The oropharyngeal swab test was positive for SARS-CoV-2. The brain MRI results were normal. Cerebrospinal fluid testing showed normal cell counts, a negative result on reverse-transcription polymerase chain reaction testing, and no oligoclonal banding. Brain 18F-FDG PET showed diffuse cortical hypometabolism associated with putaminal and cerebellum hypermetabolism, compatible with encephalitis and especially cerebellitis. The immunologic study revealed high titers of IgG autoantibodies in serum and cerebrospinal fluid directed against the nuclei of Purkinje cells, striatal neurons, and hippocampal neurons. Whole-body 18F-FDG PET and CT scans did not show neoplasia. Treatment with steroids allowed a rapid improvement in symptoms. Conclusion: This clinical case argues for a possible relationship between SARS-CoV-2 infection and autoimmune encephalitis and for the use of 18F-FDG PET in such a context.

Keywords: 18F-FDG PET; COVID-19; SARS-CoV-2; autoimmune encephalitis; methylprednisolone.

© 2020 by the Society of Nuclear Medicine and Molecular Imaging.

Figures

FIGURE 1.
FIGURE 1.
18F-FDG brain, whole-body PET, and brain MRI findings. (A and B) Brain 18F-FDG PET sagittal and axial slices showing diffuse cortical hypometabolism associated with putaminal and cerebellum hypermetabolism (A), confirmed by SPM comparison to 20 healthy elderly subjects (B) (P < 0.001, k > 600). (C and D) Whole-body 18F-FDG PET/CT showing slight lung and hilar lymph node hypermetabolism on maximum-intensity projection (C) and axial fused slices (D), matching pseudonodular retractile consolidation postinfectious findings on CT, without straightforward argument for neoplasia. (E) Axial slices from T2-weighted fluid-attenuated inversion recovery MRI of putamen and cerebellum showing no abnormalities.
FIGURE 2.
FIGURE 2.
Immunostaining of neuronal nuclei; 25-μm sections were obtained from frozen rat nerve tissue and incubated with different dilutions of serum or CSF and peroxidase-labeled anti-IgG antisera. Immunostaining was revealed in presence of 3-amino-9-ethylcarbazole. This NDP.view2 (Hamamatsu) figure shows labeling with CSF diluted to one sixth on nuclei of Purkinje cells in cerebellum, as well as striatal and hippocampal neurons.

References

    1. Wang D, Hu B, Hu C, et al. . Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061–1069.
    1. Mao L, Jin H, Wang M, et al. . Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683–690.
    1. Toscano G, Palmerini F, Ravaglia S, et al. . Guillain–Barré syndrome associated with SARS-CoV-2. N Engl J Med. 2020;382:2574–2576.
    1. Moriguchi T, Harii N, Goto J, et al. . A first case of meningitis/encephalitis associated with SARS-coronavirus-2. Int J Infect Dis. 2020;94:55–58.
    1. Guedj E, Verger A, Cammilleri S. PET imaging of COVID-19: the target and the number. Eur J Nucl Med Mol Imaging. 2020;47:1636–1637.
    1. Steardo L, Steardo L, Jr, Zorec R, Verkhratsky A. Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19. Acta Physiol (Oxf). 2020;229:e13473.
    1. Baumgartner A, Rauer S, Mader I, Meyer PT. Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types. J Neurol. 2013;260:2744–2753.
    1. Macher S, Zimprich F, De Simoni D, Höftberger R, Rommer PS. Management of autoimmune encephalitis: an observational monocentric study of 38 patients. Front Immunol. 2018;9:2708.
    1. Solnes LB, Jones KM, Rowe SP, et al. . Diagnostic value of 18F-FDG PET/CT versus MRI in the setting of antibody-specific autoimmune encephalitis. J Nucl Med. 2017;58:1307–1313.
    1. Jarius S, Hoffmann L, Clover L, Vincent A, Voltz R. CSF findings in patients with voltage gated potassium channel antibody associated limbic encephalitis. J Neurol Sci. 2008;268:74–77.
    1. van Sonderen A, Ariño H, Petit-Pedrol M, et al. . The clinical spectrum of Caspr2 antibody–associated disease. Neurology. 2016;87:521–528.
    1. Setti L, Kirienko M, Dalto SC, Bonacina M, Bombardieri E. FDG-PET/CT findings highly suspicious for COVID-19 in an Italian case series of asymptomatic patients. Eur J Nucl Med Mol Imaging. 2020;47:1649–1656.
    1. Oxford University news release low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19. Randomised Evaluation of COVID-19 Therapy website. . Published June 16, 2020. Accessed October 6, 2020.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever